These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171 [TBL] [Abstract][Full Text] [Related]
45. Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors. Pedersen-Bjergaard U Dan Med Bull; 2009 Nov; 56(4):193-207. PubMed ID: 19939337 [TBL] [Abstract][Full Text] [Related]
46. Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists. Johnsen SP; Jacobsen J; Monster TB; Friis S; McLaughlin JK; Sørensen HT Am J Med; 2005 Dec; 118(12):1428-9. PubMed ID: 16378805 [No Abstract] [Full Text] [Related]
47. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis. Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200 [TBL] [Abstract][Full Text] [Related]
48. [Hypoglycemia--a problem in insulin therapy?]. Otto-Buczkowska E; Jarosz-Chobot P Przegl Lek; 1996; 53(6):497-500. PubMed ID: 8819360 [TBL] [Abstract][Full Text] [Related]
50. A clinical moment with ... diabetes. Why did my symptoms of hypoglycemia change? DeLawter DE Md Med J; 1991 Jul; 40(7):594. PubMed ID: 1861589 [No Abstract] [Full Text] [Related]
51. An update on the long-acting insulin analogue glargine. Thisted H; Johnsen SP; Rungby J Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163 [TBL] [Abstract][Full Text] [Related]
52. Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus. Webster J; Murchison LE; Robb OJ Scott Med J; 1988 Apr; 33(2):247-8. PubMed ID: 2840738 [TBL] [Abstract][Full Text] [Related]
53. Effect of angiotensin-converting enzyme inhibition on pituitary hormone responses to insulin-induced hypoglycemia in humans. Winer LM; Molteni A; Molitch ME J Clin Endocrinol Metab; 1990 Jul; 71(1):256-9. PubMed ID: 2164528 [TBL] [Abstract][Full Text] [Related]
54. [Hypoglycemia experienced by insulin-treated diabetics]. Goldgewicht C; Slama G; Papoz L; Gin H; Soria J; Desplanque N; Tchobroutsky G Journ Annu Diabetol Hotel Dieu; 1981; ():247-56. PubMed ID: 7017226 [No Abstract] [Full Text] [Related]
55. [Does recurrent exposure to severe hypoglycaemia affect cognitive function?]. Frier BM Pol Arch Med Wewn; 2007 Aug; 117(8):341-2. PubMed ID: 18018380 [No Abstract] [Full Text] [Related]
56. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy. Pathak JV; Dass EE Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372 [TBL] [Abstract][Full Text] [Related]
58. [Is it necessary to systematically treat diabetics with ACE inhibitors?]. Marre M; Collet C; Stevenin C Journ Annu Diabetol Hotel Dieu; 2001; ():185-7. PubMed ID: 11565461 [No Abstract] [Full Text] [Related]
59. Hypoglycaemia as cause of death in human insulin era. Stephenson J; Fuller J Lancet; 1990 Mar; 335(8690):661. PubMed ID: 1969036 [No Abstract] [Full Text] [Related]